Adequan® Canine is an FDA-approved injectable treatment for non‑infectious degenerative and traumatic arthritis in dogs.
Its active ingredient, polysulfated glycosaminoglycan (PSGAG), helps restore joint health by reducing inflammation and slowing cartilage deterioration.
Administered intramuscularly twice a week for up to four weeks, Adequan offers a science-based way to support your dog’s mobility and long-term joint function.